Patent · US Active

GPR119 agonists

US8207344B2 · kind B2 · utility

0Cited by
0References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 12, 2010
Grant dateJun 26, 2012
Priority date—
Expiry dateDec 28, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

GPR119 agonist compounds of the formula:and pharmaceutical compositions for the treatment of diabetes and obesity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.